Table 1.
Comparisons of general data between the two groups.
| Items | CAS group (n = 19) | Control group (n = 28) | P |
|---|---|---|---|
| Age (year) | 57.0 ± 1.2 | 54.9 ± 1.5 | 0.347 |
| Sex (male/female) | 13/6 | 18/10 | 0.769 |
| Smoking (%) | 57.9 | 25.0 | 0.023 |
| Diabetes (%) | 15.8 | 14.3 | 0.887 |
| LVEF(%) | 63.3 ± 1.1 ' | 63.0 ± 1.3 | 0.831 |
| BMI (kg/m2) | 23.0 ± 1.0 | 23.5 ± 0.7 | 0.648 |
| Systolic pressure (mmHg) | 130.7 ± 6.1 | 133.1 ± 3.4 | 0.715 |
| Diastolic pressure (mmHg) | 84.9 ± 3.4 | 85.5 ± 2.5 | 0.883 |
| Fasting blood glucose (mM) | 5.75 ± 0.19 | 5.84 ± 0.24 | 0.804 |
| Serum creatinine (μM) | 66.5 ± 3.0 | 63.7 ± 3.7 | 0.563 |
| Blood urea nitrogen (mM) | 5.04 ± 0.24 | 5.32 ± 0.29 | 0.497 |
| Triglyceride (mM) | 1.64 ± 0.15 | 1.75 ± 0.20 | 0.674 |
| Total cholesterol (mM) | 4.60 ± 0.17 | 4.50 ± 0.13 | 0.6229 |
| LDL-C(mM) | 2.73 ± 0.17 | 2.35 ± 0.09 | 0.034 |
| HDL-C(mM) | 1.26 ± 0.05 | 1.27 ± 0.05 | 0.939 |
| ACEI/ARB (%) | 68.4 | 71.4 | 0.825 |
| Statins (%) | 47.4 | 50.0 | 0.859 |
| Aspirin (%) | 89.5 | 85.7 | 0.705 |
CAS: coronary artery spasm; LVEF: left ventricular ejection fractio; BMI: body mass index; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.